Please use this identifier to cite or link to this item:
Title: Studies of the anticancer potential of andrographolide in human cancer cells
Authors: ZHOU JING
Keywords: Andrographolide, apoptosis, Bcl-2, ROS, p53, STAT3
Issue Date: 4-Jun-2009
Source: ZHOU JING (2009-06-04). Studies of the anticancer potential of andrographolide in human cancer cells. ScholarBank@NUS Repository.
Abstract: The anticancer property of Andro, a major component extracted from Andrographis paniculata, has been systematically investigated in this study. The whole study can be divided into three parts: Andro exerts its anti-tumor effect by inducing caspase-dependent apoptosis through Bid-mediated mitochondrial pathway; Andro sensitizes TRAIL-induced apoptosis in cancer cells by p53-dependent DR4 up-regulation via ROS accumulation; Andro enhances the anticancer activity of doxorubicin by down-regulating anti-apoptotic proteins via suppression of STAT3 activation. In summary, data from this study demonstrate that Andro could be a potent anticancer agent through inducing apoptosis in various cancer cells. More importantly, this study provides evidence showing that Andro is highly capable of sensitizing TRAIL and doxorubicin-induced cancer cell apoptosis. Such findings support the potential application of Andro as a potent apoptosis inducer and chemo-sensitizer in cancer therapy.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ZhouJing thesis-2009.pdf2.7 MBAdobe PDF



Page view(s)

checked on Dec 11, 2017


checked on Dec 11, 2017

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.